Figlin RA - Search Results

1

Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program.

Bukowski RM, Stadler WM, McDermott DF, Dutcher JP, Knox JJ, Miller WH Jr, Hainsworth JD, Henderson CA, Hajdenberg J, Kindwall-Keller TL, Ernstoff MS, Drabkin HA, Curti BD, Chu L, Ryan CW, Hotte SJ, Xia C, Cupit L, Figlin RA. Bukowski RM, et al. Among authors: figlin ra. Oncology. 2010;78(5-6):340-7. doi: 10.1159/000320223. Epub 2010 Aug 20. Oncology. 2010. PMID: 20733337

2

Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors.

Janik JE, Sznol M, Urba WJ, Figlin R, Bukowski RM, Fyfe G, Pierce WC, Belldegrun A, Sharfman WH, Smith JW 2nd, et al. Janik JE, et al. Cancer. 1993 Nov 1;72(9):2656-9. doi: 10.1002/1097-0142(19931101)72:9<2656::aid-cncr2820720922>3.0.co;2-a. Cancer. 1993. PMID: 8402486

3

Renal cell carcinoma: basic biology and clinical behavior.

Franklin JR, Figlin R, Belldegrun A. Franklin JR, et al. Semin Urol Oncol. 1996 Nov;14(4):208-15. Semin Urol Oncol. 1996. PMID: 8946619 Review.

4

Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.

Franklin JR, Figlin R, Rauch J, Gitlitz B, Belldegrun A. Franklin JR, et al. Semin Urol Oncol. 1996 Nov;14(4):230-6. Semin Urol Oncol. 1996. PMID: 8946623

5

Renal cell carcinoma: management of advanced disease.

Figlin RA. Figlin RA. J Urol. 1999 Feb;161(2):381-6; discussion 386-7. doi: 10.1016/s0022-5347(01)61897-4. J Urol. 1999. PMID: 9915408 Review.

6

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma.

Figlin RA, Thompson JA, Bukowski RM, Vogelzang NJ, Novick AC, Lange P, Steinberg GD, Belldegrun AS. Figlin RA, et al. J Clin Oncol. 1999 Aug;17(8):2521-9. doi: 10.1200/JCO.1999.17.8.2521. J Clin Oncol. 1999. PMID: 10561318 Clinical Trial.

7

Improved prognostication of renal cell carcinoma using an integrated staging system.

Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: figlin ra. J Clin Oncol. 2001 Mar 15;19(6):1649-57. doi: 10.1200/JCO.2001.19.6.1649. J Clin Oncol. 2001. PMID: 11250993

8

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

Khuri FR, Rigas JR, Figlin RA, Gralla RJ, Shin DM, Munden R, Fox N, Huyghe MR, Kean Y, Reich SD, Hong WK. Khuri FR, et al. Among authors: figlin ra. J Clin Oncol. 2001 May 15;19(10):2626-37. doi: 10.1200/JCO.2001.19.10.2626. J Clin Oncol. 2001. PMID: 11352954 Clinical Trial.

9

Mathematical model to predict individual survival for patients with renal cell carcinoma.

Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: figlin ra. J Clin Oncol. 2002 Mar 1;20(5):1368-74. doi: 10.1200/JCO.2002.20.5.1368. J Clin Oncol. 2002. PMID: 11870181

10

Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma.

Motzer RJ, Rakhit A, Thompson J, Gurney H, Selby P, Figlin R, Negrier S, Ernst S, Siebels M, Ginsberg M, Rittweger K, Hooftman L. Motzer RJ, et al. Ann Oncol. 2002 Nov;13(11):1799-805. doi: 10.1093/annonc/mdf288. Ann Oncol. 2002. PMID: 12419754 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters